908 Devices Inc (MASS) - Total Assets
Based on the latest financial reports, 908 Devices Inc (MASS) holds total assets worth $186.69 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 908 Devices Inc (MASS) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
908 Devices Inc - Total Assets Trend (2018–2025)
This chart illustrates how 908 Devices Inc's total assets have evolved over time, based on quarterly financial data. Check 908 Devices Inc (MASS) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
908 Devices Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
908 Devices Inc's total assets of $186.69 Million consist of 76.1% current assets and 23.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 59.4% |
| Accounts Receivable | $11.33 Million | 6.0% |
| Inventory | $12.99 Million | 6.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $36.41 Million | 19.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how 908 Devices Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see MASS company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: 908 Devices Inc's current assets represent 76.1% of total assets in 2025, an increase from 62.0% in 2018.
- Cash Position: Cash and equivalents constituted 59.4% of total assets in 2025, up from 25.5% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is intangible assets at 19.2% of total assets.
908 Devices Inc Competitors by Total Assets
Key competitors of 908 Devices Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.62 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
908 Devices Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.58 | 7.62 | 14.06 |
| Quick Ratio | 3.25 | 6.97 | 13.35 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $102.35 Million | $129.44 Million | $146.01 Million |
908 Devices Inc - Advanced Valuation Insights
This section examines the relationship between 908 Devices Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.49 |
| Latest Market Cap to Assets Ratio | 1.58 |
| Asset Growth Rate (YoY) | 19.2% |
| Total Assets | $190.07 Million |
| Market Capitalization | $299.86 Million USD |
Valuation Analysis
Above Book Valuation: The market values 908 Devices Inc's assets above their book value (1.58x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: 908 Devices Inc's assets grew by 19.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for 908 Devices Inc (2018–2025)
The table below shows the annual total assets of 908 Devices Inc from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $190.07 Million | +19.18% |
| 2024-12-31 | $159.48 Million | -21.43% |
| 2023-12-31 | $202.98 Million | -16.33% |
| 2022-12-31 | $242.59 Million | -7.02% |
| 2021-12-31 | $260.91 Million | +45.90% |
| 2020-12-31 | $178.83 Million | +374.82% |
| 2019-12-31 | $37.66 Million | +35.73% |
| 2018-12-31 | $27.75 Million | -- |
About 908 Devices Inc
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spe… Read more